Literature DB >> 20020828

Innate immune evasion strategies of influenza viruses.

Benjamin G Hale1, Randy A Albrecht, Adolfo García-Sastre.   

Abstract

Influenza viruses are globally important human respiratory pathogens. These viruses cause seasonal epidemics and occasional worldwide pandemics, both of which can vary significantly in disease severity. The virulence of a particular influenza virus strain is partly determined by its success in circumventing the host immune response. This article briefly reviews the innate mechanisms that host cells have evolved to resist virus infection, and outlines the plethora of strategies that influenza viruses have developed in order to counteract such powerful defences. The molecular details of this virus-host interplay are summarized, and the ways in which research in this area is being applied to the rational design of protective vaccines and novel antivirals are discussed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20020828      PMCID: PMC2820251          DOI: 10.2217/fmb.09.108

Source DB:  PubMed          Journal:  Future Microbiol        ISSN: 1746-0913            Impact factor:   3.165


  197 in total

1.  Influenza A virus NS1 protein prevents activation of NF-kappaB and induction of alpha/beta interferon.

Authors:  X Wang; M Li; H Zheng; T Muster; P Palese; A A Beg; A García-Sastre
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  The influenza A virus NS1 protein inhibits activation of Jun N-terminal kinase and AP-1 transcription factors.

Authors:  Stephan Ludwig; Xiuyan Wang; Christina Ehrhardt; Hongyong Zheng; Nicola Donelan; Oliver Planz; Stephan Pleschka; Adolfo García-Sastre; Gudrun Heins; Thorsten Wolff
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

3.  Influenza A virus NS1 protein activates the PI3K/Akt pathway to mediate antiapoptotic signaling responses.

Authors:  Christina Ehrhardt; Thorsten Wolff; Stephan Pleschka; Oliver Planz; Wiebke Beermann; Johannes G Bode; Mirco Schmolke; Stephan Ludwig
Journal:  J Virol       Date:  2007-01-17       Impact factor: 5.103

Review 4.  Toll-like receptor and RIG-I-like receptor signaling.

Authors:  Taro Kawai; Shizuo Akira
Journal:  Ann N Y Acad Sci       Date:  2008-11       Impact factor: 5.691

5.  A novel RNA-binding motif in influenza A virus non-structural protein 1.

Authors:  C Y Chien; R Tejero; Y Huang; D E Zimmerman; C B Ríos; R M Krug; G T Montelione
Journal:  Nat Struct Biol       Date:  1997-11

6.  DAS181, a novel sialidase fusion protein, protects mice from lethal avian influenza H5N1 virus infection.

Authors:  Jessica A Belser; Xiuhua Lu; Kristy J Szretter; Xiaoping Jin; Laura M Aschenbrenner; Alice Lee; Stephen Hawley; Do Hyong Kim; Michael P Malakhov; Mang Yu; Fang Fang; Jacqueline M Katz
Journal:  J Infect Dis       Date:  2007-10-31       Impact factor: 5.226

7.  SH3 binding motif 1 in influenza A virus NS1 protein is essential for PI3K/Akt signaling pathway activation.

Authors:  Yeun-Kyung Shin; Yang Li; Qiang Liu; Deborah H Anderson; Lorne A Babiuk; Yan Zhou
Journal:  J Virol       Date:  2007-09-19       Impact factor: 5.103

8.  Control of apoptosis in influenza virus-infected cells by up-regulation of Akt and p53 signaling.

Authors:  Oleg P Zhirnov; Hans-Dieter Klenk
Journal:  Apoptosis       Date:  2007-08       Impact factor: 4.677

9.  Intranasal administration of alpha interferon reduces seasonal influenza A virus morbidity in ferrets.

Authors:  Daniela Kugel; Georg Kochs; Karola Obojes; Joachim Roth; Gary P Kobinger; Darwyn Kobasa; Otto Haller; Peter Staeheli; Veronika von Messling
Journal:  J Virol       Date:  2009-02-04       Impact factor: 5.103

10.  Inflammasome recognition of influenza virus is essential for adaptive immune responses.

Authors:  Takeshi Ichinohe; Heung Kyu Lee; Yasunori Ogura; Richard Flavell; Akiko Iwasaki
Journal:  J Exp Med       Date:  2009-01-12       Impact factor: 14.307

View more
  66 in total

1.  Molecular signatures associated with Mx1-mediated resistance to highly pathogenic influenza virus infection: mechanisms of survival.

Authors:  Cristian Cilloniz; Mary J Pantin-Jackwood; Chester Ni; Victoria S Carter; Marcus J Korth; David E Swayne; Terrence M Tumpey; Michael G Katze
Journal:  J Virol       Date:  2011-12-21       Impact factor: 5.103

2.  Schlafen 14 (SLFN14) is a novel antiviral factor involved in the control of viral replication.

Authors:  Rak-Kyun Seong; Seong-Wook Seo; Ji-Ae Kim; Sarah J Fletcher; Neil V Morgan; Mukesh Kumar; Young-Ki Choi; Ok Sarah Shin
Journal:  Immunobiology       Date:  2017-07-11       Impact factor: 3.144

3.  Cytokine production in whole-blood cultures following immunization with an influenza vaccine.

Authors:  Tetsuo Nakayama; Takuji Kumagai; Yasuyo Kashiwagi; Hironori Yoshii; Kenta Honjo; Ritsuko Kubota-Koketsu; Yoshinobu Okuno; Shigeru Suga
Journal:  Hum Vaccin Immunother       Date:  2018-08-28       Impact factor: 3.452

Review 4.  Cytoplasm and Beyond: Dynamic Innate Immune Sensing of Influenza A Virus by RIG-I.

Authors:  GuanQun Liu; Yan Zhou
Journal:  J Virol       Date:  2019-04-03       Impact factor: 5.103

Review 5.  Inhaled corticosteroids and risk of influenza in patients with asthma: a meta-analysis of randomized controlled trials.

Authors:  Hong Chen; Zhibo Xu; Jing Yang; Lan Huang; Ke Wang
Journal:  Aging Clin Exp Res       Date:  2020-10-07       Impact factor: 3.636

6.  Attenuated influenza virus construct with enhanced hemagglutinin protein expression.

Authors:  Jad Maamary; Natalie Pica; Alan Belicha-Villanueva; Yi-ying Chou; Florian Krammer; Qinshan Gao; Adolfo García-Sastre; Peter Palese
Journal:  J Virol       Date:  2012-03-07       Impact factor: 5.103

7.  Adaptive Mutations That Occurred during Circulation in Humans of H1N1 Influenza Virus in the 2009 Pandemic Enhance Virulence in Mice.

Authors:  A Otte; M Sauter; M A Daxer; A C McHardy; K Klingel; G Gabriel
Journal:  J Virol       Date:  2015-05-06       Impact factor: 5.103

8.  A Novel Role for PDZ-Binding Motif of Influenza A Virus Nonstructural Protein 1 in Regulation of Host Susceptibility to Postinfluenza Bacterial Superinfections.

Authors:  Kelly Shepardson; Kyle Larson; Hanbyul Cho; Laura Logan Johns; Zeynep Malkoc; Kayla Stanek; Julia Wellhman; Sarah Zaiser; Jaelyn Daggs-Olson; Travis Moodie; Joshua M Klonoski; Victor C Huber; Agnieszka Rynda-Apple
Journal:  Viral Immunol       Date:  2019-03-01       Impact factor: 2.257

Review 9.  H5N1 pathogenesis studies in mammalian models.

Authors:  Jessica A Belser; Terrence M Tumpey
Journal:  Virus Res       Date:  2013-02-28       Impact factor: 3.303

10.  Quantitative Proteomic Approach Identifies Vpr Binding Protein as Novel Host Factor Supporting Influenza A Virus Infections in Human Cells.

Authors:  Anne Sadewasser; Katharina Paki; Katrin Eichelbaum; Boris Bogdanow; Sandra Saenger; Matthias Budt; Markus Lesch; Klaus-Peter Hinz; Andreas Herrmann; Thomas F Meyer; Alexander Karlas; Matthias Selbach; Thorsten Wolff
Journal:  Mol Cell Proteomics       Date:  2017-03-13       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.